APP:CC - GCAC CEO to Deliver Keynote Address at Cannabis Business Europe 2022 in Frankfurt
(TheNewswire)
BradMoore delivers follow up talk to 2021 conference
Vancouver, British Columbia, Canada– TheNewswire - April 26, 2022 – Global CannabisApplications Corp. (" GCAC" or the" Company" ) ( CSE:APP ) , ( FSE:2FA ) , ( OTC:FUAPF ), a leading medical cannabis chain-of-custody compliance anddata platform, announced CEO Brad Moore has beeninvited to deliver a keynote speech at Cannabis Business Europe inFrankfurt, Germany, June 14 at 9:45 am. Brad will also join a Q&ARoundtable with event speakers later that day.
In his speech “Dosing: Where Does the ResponsibilityLie?” Brad will highlight the challenges cannabis cultivators facein measuring a plant and the lack of available data. He will presentGCAC’s cultivator-to-consumer solution to over 400 industryprofessionals.
“Consistently growing cannabis is hard. The slightestinput can dramatically change the desired outcome, resulting in a lossof sales and brand reputation. Data recording and tracking of theplant’s lifecycle is lacking. GCAC’s Efixii is the world’s firstpatent-pending blockchain solution for the cannabis industry,” saysCEO Brad Moore.
The Efixii blockchain solution records every step inthe cannabis plant lifecycle from seed to the consumer and back. Dataon a blockchain remains forever, it cannot be altered, and everyonecan view it. There are quantifiable benefits for every supply chainsegment, including consumers.
Moore adds, “Our SeedtoSeed TM real-timefeedback loop cements a relationship from cultivator to consumer andback, including every stakeholder. Scanning a secure Efixii QR codeshows each step for improved data and transparency. The free-to-useconsumer app lets you read and submit genuine product reviewsmeasuring ‘one gram grown, one gram consumed.’ Enriched productknowledge for better outcomes.”
The information is fed back through the entire system,allowing cultivators, manufacturers and retailers to understand whatworked and why. They can review each detail to develop repeatableprocesses and consistent cannabis. Manufacturers and retailers alsobenefit from Efixii data to streamline supply chain efficiencies andsource the best product.
Efixii is licensed to cultivators in a SaaS model andis a free-to-use app for cannabis consumers. All cannabis sold throughthe Portal generates a new sales-commission revenue stream for GCAC.Efixii’s cannabis data is the intellectual property (“IP”) ofGCAC. This IP creates an inherent difficulty in replicating orcompeting with GCAC’s cannabis datasets. GCAC defined theirprotocols in a provisional U.S. patent application, ‘System ofProcess and Tracking Cannabis Products and Associated Method UsingBlockchain’ filed with the USPTO on Dec. 17, 2020.
About Global Cannabis ApplicationsCorp. “GCAC”
GCAC is a global leader in designing, developing, SaaSlicensing and acquiring innovative data technologies for the medicalcannabis industry. The Citizen Green and Efixii platforms are theworld's first end-to-end - from patient to regulator - medicalcannabis data solutions. They use six core technologies: mobileapplications, artificial intelligence, RegTech, smart databases,Ethereum blockchain and GCAC smart rewards. These technologiestransparently disclose cannabis chain-of-custody events, enablingpatients to provide crowd-sourced medical cannabis efficacy data.Driven by digital and cannabis industry experts, GCAC is focused ongenerating revenue from SaaS licensing its technology and acquiringhigh-quality cannabis datasets that improve patient outcomes andbecome the world’s largest cannabis efficacy data provider.
For more Company information, please visit www.cannappscorp.com , or review itsprofiles on www.sedar.com and on the Canadian Securities Exchange's website www.thecse.com .
PressContact
Phone: +1 (800) 409-5679
Email: info@cannappscorp.com
Forward-Looking Information
This news release mayinclude forward-looking information within the meaning of Canadiansecurities legislation concerning the business of GCAC.Forward-looking information is based on certain key expectations andassumptions made by the management of GCAC. Although management of theCompany believes that the expectations and assumptions on which suchforward-looking information is based are reasonable, undue relianceshould not be placed on the forward-looking information because GCACcan give no assurance that they will prove to be correct.Forward-looking statements contained in this news release are made asof the date of this news release. GCAC disclaims any intent orobligation to update publicly any forward-looking information, whetheras a result of new information, future events or results or otherwise,other than as required by applicable securities laws.
The CanadianSecurities Exchange has not reviewed and does not acceptresponsibility for the adequacy and accuracy of thisinformation.
Copyright (c) 2022 TheNewswire - All rights reserved.